ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY
Objective: To evaluate the success rate of injection ‘methotrexate’ in the management of ectopic pregnancy. Study Design: A single group interventional study. Place and Duration of Study: NESCOM Hospital Islamabad, from Jan 2014 to Dec 2017. Methodology: All patients admitted with ectopic p...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Army Medical College Rawalpindi
2020-10-01
|
| Series: | Pakistan Armed Forces Medical Journal |
| Subjects: | |
| Online Access: | https://www.pafmj.org/index.php/PAFMJ/article/view/5554/2957 |
| _version_ | 1818729817565036544 |
|---|---|
| author | Mussarat Sultana Saima Perveen Sadia Kashif Huma Karamat Fasih Hashmi |
| author_facet | Mussarat Sultana Saima Perveen Sadia Kashif Huma Karamat Fasih Hashmi |
| author_sort | Mussarat Sultana |
| collection | DOAJ |
| description | Objective: To evaluate the success rate of injection ‘methotrexate’ in the management of ectopic pregnancy.
Study Design: A single group interventional study.
Place and Duration of Study: NESCOM Hospital Islamabad, from Jan 2014 to Dec 2017.
Methodology: All patients admitted with ectopic pregnancy fulfilling the inclusion criteria i.e, a stable clinical condition, no evidence of rupture on ultrasound, normal liver and renal functions were included in the study, while the patients who were showing signs of rupture ectopic or with abnormal liver and renal functions were excluded from the study. Data was collected on predesigned performa. Diagnostic tools were Transvaginal Sonography and serial serum β-human chorionic gonadotropin levels .These patients were treated with injection methotrexate 50 mg/kg body weight. Serum β-human chorionic gonadotropin levels were done on day 4 and day 7 and weekly thereafter till ≤5 mIU/ml.
Results: The total number of patients (88) with 18-39 years, fulfilling the inclusion criteria were given injection methotrexate. Medical treatment was successful in 81.8% of patients whereas failure was observed in 18.2%. Among which 67 patients were given single dose, 20 patients received 2 doses and only 01 patient needed 3 doses. The mean resolution time for β-human chorionic gonadotropin level was 21 days (11-58). Average resolution time for adnexal masses (<3cm) was 19 days and for adnexal masses (>3cm) was 39 days.
Conclusion: Methotrexate was found to be safe, cost effective and fertility preserving alternative to the surgical management of ectopic pregnancy. |
| first_indexed | 2024-12-17T22:51:55Z |
| format | Article |
| id | doaj.art-dcbe3a9cf54148c093d4a3a0a02c5480 |
| institution | Directory Open Access Journal |
| issn | 0030-9648 2411-8842 |
| language | English |
| last_indexed | 2024-12-17T22:51:55Z |
| publishDate | 2020-10-01 |
| publisher | Army Medical College Rawalpindi |
| record_format | Article |
| series | Pakistan Armed Forces Medical Journal |
| spelling | doaj.art-dcbe3a9cf54148c093d4a3a0a02c54802022-12-21T21:29:39ZengArmy Medical College RawalpindiPakistan Armed Forces Medical Journal0030-96482411-88422020-10-0170513051309ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCYMussarat Sultana0Saima Perveen1Sadia Kashif2Huma Karamat3Fasih Hashmi4NESCOM Hospital Islamabad PakistanMohtarma Benazir Bhutto Shaheed Medical College, Mirpur, Azad Kashmir, PakistanNESCOM Hospital Islamabad PakistanNESCOM Hospital Islamabad PakistanCollege of Physicians and Surgeons Pakistan (CPSP), Islamabad PakistanObjective: To evaluate the success rate of injection ‘methotrexate’ in the management of ectopic pregnancy. Study Design: A single group interventional study. Place and Duration of Study: NESCOM Hospital Islamabad, from Jan 2014 to Dec 2017. Methodology: All patients admitted with ectopic pregnancy fulfilling the inclusion criteria i.e, a stable clinical condition, no evidence of rupture on ultrasound, normal liver and renal functions were included in the study, while the patients who were showing signs of rupture ectopic or with abnormal liver and renal functions were excluded from the study. Data was collected on predesigned performa. Diagnostic tools were Transvaginal Sonography and serial serum β-human chorionic gonadotropin levels .These patients were treated with injection methotrexate 50 mg/kg body weight. Serum β-human chorionic gonadotropin levels were done on day 4 and day 7 and weekly thereafter till ≤5 mIU/ml. Results: The total number of patients (88) with 18-39 years, fulfilling the inclusion criteria were given injection methotrexate. Medical treatment was successful in 81.8% of patients whereas failure was observed in 18.2%. Among which 67 patients were given single dose, 20 patients received 2 doses and only 01 patient needed 3 doses. The mean resolution time for β-human chorionic gonadotropin level was 21 days (11-58). Average resolution time for adnexal masses (<3cm) was 19 days and for adnexal masses (>3cm) was 39 days. Conclusion: Methotrexate was found to be safe, cost effective and fertility preserving alternative to the surgical management of ectopic pregnancy.https://www.pafmj.org/index.php/PAFMJ/article/view/5554/2957ectopic pregnancymethotrexate |
| spellingShingle | Mussarat Sultana Saima Perveen Sadia Kashif Huma Karamat Fasih Hashmi ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY Pakistan Armed Forces Medical Journal ectopic pregnancy methotrexate |
| title | ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY |
| title_full | ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY |
| title_fullStr | ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY |
| title_full_unstemmed | ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY |
| title_short | ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY |
| title_sort | role of injection methotrexate in the management of ectopic pregnancy |
| topic | ectopic pregnancy methotrexate |
| url | https://www.pafmj.org/index.php/PAFMJ/article/view/5554/2957 |
| work_keys_str_mv | AT mussaratsultana roleofinjectionmethotrexateinthemanagementofectopicpregnancy AT saimaperveen roleofinjectionmethotrexateinthemanagementofectopicpregnancy AT sadiakashif roleofinjectionmethotrexateinthemanagementofectopicpregnancy AT humakaramat roleofinjectionmethotrexateinthemanagementofectopicpregnancy AT fasihhashmi roleofinjectionmethotrexateinthemanagementofectopicpregnancy |